See also this year's filing and all EDGAR filings for this company.
PDF Report 0001048477_2017_BIOMARIN_PHARMACEUTICAL_INC.pdf
Logs
warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 2.0, 'aggregate_val': -1116854000, 'exp_sum': 1116854000, 'exp_to_value': {'remainder_Revenues': 1116854000}} |
warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 2.630510148141688, 'aggregate_val': 2331107000, 'exp_sum': 642088000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 209620000, 'SellingGeneralAndAdministrativeExpense': 476593000, 'ResearchAndDevelopmentExpense': 661905000, 'remainder_Expenses': -706030000}} |
warning | Expenses in unusual place in relation to revenue | input.sec.calculation_linkbase.edgar_model_mapping | {'expenses_node': 'CostsAndExpenses', 'revenue_node': 'Revenues', 'net_inc_node': 'NetIncomeLoss'} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001048477, BIOMARIN PHARMACEUTICAL INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 1,421,791,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 750,819,000 |
2 | PropertyPlantAndEquipmentNet | 798,768,000 |
3 | remainder_Assets | 1,052,312,000 |
4 | LiabilitiesCurrent | 439,310,000 |
5 | LiabilitiesNoncurrent | 42,034,000 |
6 | remainder_Liabilities | 776,071,000 |
7 | CostOfGoodsAndServicesSold | 209,620,000 |
8 | SellingGeneralAndAdministrativeExpense | 476,593,000 |
9 | ResearchAndDevelopmentExpense | 661,905,000 |
10 | remainder_Expenses | 982,989,000 |
11 | remainder_Revenues | -1,116,854,000 |
12 | remainder_NetIncome | 11,878,000 |
13 | remainder_ComprehensiveNetIncome | -8,217,000 |
yvar | yval | |
---|---|---|
0 | Assets | 4,023,690,000 |
1 | Liabilities | 1,257,415,000 |
2 | Expenses | 2,331,107,000 |
3 | Revenues | -1,116,854,000 |
4 | StockholdersEquity | 2,766,275,000 |
5 | NetIncome | -3,436,083,000 |
6 | ComprehensiveNetIncome | -3,440,191,500 |
7 | BaseVar | 4,374,580,500 |
8 | EconomicCapitalRatio | 0.499 |